Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1183.6000 15.40 (1.32%)
NSE Nov 12, 2025 15:31 PM
Volume: 2.4M
 

logo
Aurobindo Pharma Ltd.
07 Nov 2025
1183.60
1.32%
buy
by Axis Direct
Target: 1345 | Upside : 13.6%
Axis Direct
We maintain our BUY recommendation on the stock with a TP of Rs 1,345/share.
 
Aurobindo Pharma Ltd. is trading above all available SMAs
More from Aurobindo Pharma Ltd.
Recommended
Market closes higher, Adani Enterprises announces Rs 24,930 crore rights issue
Trendlyne Marketwatch | 12 Nov 2025, 04:11PM
Retail investors have driven an IPO boom in 2025
The Baseline | 12 Nov 2025, 12:42PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020